If prospective cohort studies are conducted in the future, with long-term follow-up of pediatric patients, detection of changes in ACSL4 and LPCAT3 at different disease stages in the same patient, and analysis of their correlations with disease recurrence, progression, and treatment, it will be of significant value for the clinical diagnosis and treatment of pediatric CD. The gene discussed is ACSL4; the disease is Cowden disease.